The proposed bill, known as the Chemical Abortion Safety Protocol Act, aims to establish specific protocols and requirements for the provision of abortion-inducing drugs in Nebraska. It introduces definitions for key terms such as "abortion-inducing drug," "adverse event," and "provide," and mandates that physicians must conduct an in-person examination of the woman, verify her pregnancy, and assess for ectopic pregnancies before administering such drugs. Additionally, the bill requires physicians to schedule a follow-up visit within a specified timeframe to confirm the termination of pregnancy and document any adverse events that may occur.

Furthermore, the bill amends existing law regarding unprofessional conduct for physicians by including violations of the Chemical Abortion Safety Protocol Act as grounds for unprofessional conduct. It also stipulates that reports must be filed with the Department of Health and Human Services detailing the administration of abortion-inducing drugs, while ensuring that no personally identifying information about the women involved is disclosed. The act includes a severability clause, ensuring that if any part of the law is found unconstitutional, the remaining sections will still be valid. The original section 38-2021 is repealed as part of this legislative update.

Statutes affected:
Introduced: 38-2021